MacKerell D Alexander, Jr

Title: MacKerell D Alexander, Jr: Innovator in Cancer Therapeutics

Introduction

MacKerell D Alexander, Jr. is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer therapeutics, particularly through his innovative research and patent work. His dedication to improving treatment options for cancer patients is evident in his patented inventions.

Latest Patents

MacKerell D Alexander, Jr. holds a patent for RUNX2 transcription factor inhibitors and their uses. This patent includes compounds with a general chemical structure where substituents R and R' can independently be H, Cl, F, Br, CH, CF, SH, —N(Calkyl), —NHC(O)Calkyl, or —NHC(O)Ccycloalkyl. The compounds are designed as therapeutics to treat cancers, such as breast cancer and metastatic cancers, by inhibiting RUNX2 activity in cancer cells. This innovation aims to increase the survival rates of subjects suffering from breast cancer.

Career Highlights

Throughout his career, MacKerell has worked with esteemed institutions, including the University System of Maryland and the United States Government as represented by the Department of Veterans Affairs. His work in these organizations has allowed him to contribute to significant advancements in cancer research and treatment.

Collaborations

MacKerell D Alexander, Jr. has collaborated with Antonino Passaniti, further enhancing the impact of his research in the field of cancer therapeutics.

Conclusion

MacKerell D Alexander, Jr. is a distinguished inventor whose work in developing RUNX2 transcription factor inhibitors showcases his commitment to advancing cancer treatment. His contributions are vital in the ongoing fight against cancer, and his innovations continue to inspire future research in this critical area.